Eye, heart and Parkinson's disease experts answer #RegenMedQs twitter questions

• Parliament TV: #RegenMedQs evidence session
• YouTube: #RegenMedQs evidence session
• Inquiry: Regenerative Medicine

A range of interesting questions were suggested and the Committee put a number of them to Professor Peng Tee Khaw from Moorfields Eye Hospital and University College London, Parkinson’s disease expert Professor Roger Barker from the University of Cambridge, and Professor Michael Schneider, a researcher funded by the British Heart Foundation.

Areas the Committee covered included whether regenerative medicine research should focus on one condition to concentrate resources, how recent changes in America regarding use of regenerative medicine to treat Stargardt's Disease would impact on treatment in the UK, and whether use should be made of tax breaks to encourage further regenerative medicine research.

#RegenMedQs

@chestnut38 #RegenMedQs is there a program with measurable and realistic goals? Ought we to be focussing on ONE condition to concentrate effort?

• YouTube: Watch Lord Rees of Ludlow ask "is there a regenerative medicine research programme with measurable and realistic goals? Should research be focussed on one condition to concentrate efforts?"
  

@tommyashe10 @UKHouseofLords #RegenMedQs Will proven safety of MA-09 hESC in clinical trial for stargardt's be advanced for compassionate use?

• YouTube: Watch Lord Turnberg ask "given the FDA’s granting of orphan status for use of MA-09 hESC in clinical trial for Stargardt's Disease, will this treatment be advanced for compassionate use in the UK?"

@euparkinsons Is there a need for improved patient education on the whole subject of regenerative medicine? Should there be better science communication strategies designed to provide accurate and realistic messages about such technologies to the public?

• YouTube: Watch Baroness Perry of Southwark ask "is there a need for improved patient education on the whole subject of regenerative medicine? Should there be better science communication strategies designed to provide accurate and realistic messages about such technologies to the public?"

@MDSociety What impact expected from EU row on commercial patents on embryonic stemcells to have on the levels of investment in research? #RegenMedQs

• YouTube: Watch Lord Patel ask "what impact do the panel expect the European Court of Justice ruling on the Brüstle vs. Greenpeace case to have on the levels of investment in research?"

@yopduk1 @UKHouseofLords #RegenMedQs what is the position re: benefits to society long term from increasing tax breaks for leading edge research?

• YouTube: Watch Lord Wade of Chorlton ask "would possible long-term benefits to society justify increasing tax breaks for promising research in regenerative medicine?"